Credit Suisse’s Strata Critical Medical Inc SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
AIM
NAMA
HVCM
BGIM
Credit Suisse's SRTA Position: Q1 2023 in Review
Credit Suisse sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 2 shares — an estimated $7 sold.
Credit Suisse first reported a position in SRTA in Q2 2022 and held it in 3 quarters. The position peaked at $128K in Q2 2022. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.
- Credit Suisse reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
- Credit Suisse sold 2 Strata Critical Medical Inc shares in Q1 2023, an estimated $7.
- Credit Suisse first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 3 quarters.
- Credit Suisse's Strata Critical Medical Inc position peaked at $128K in Q2 2022.
- 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.
Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.